These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9475490)

  • 1. Pharmacology and therapeutic applications of hirudin, a new anticoagulant.
    Glusa E
    Kidney Int Suppl; 1998 Feb; 64():S54-6. PubMed ID: 9475490
    [No Abstract]   [Full Text] [Related]  

  • 2. Bivalirudin: a review of pharmacology and therapeutic use.
    Scholle JM; White CM
    Conn Med; 2010; 74(10):595-7. PubMed ID: 21189716
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of recombinant hirudin as a therapeutic anticoagulant and antithrombotic agent: some objective considerations.
    Walenga JM; Pifarre R; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1989 Jul; 15(3):316-33. PubMed ID: 2688104
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct thrombin inhibitors in cardiovascular disease.
    Catella-Lawson F
    Coron Artery Dis; 1997 Feb; 8(2):105-11. PubMed ID: 9211051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Future directions in antithrombotic therapy: emphasis on venous thromboembolism.
    Axelrod DA; Wakefield TW
    J Am Coll Surg; 2001 May; 192(5):641-51. PubMed ID: 11333101
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative pharmacology of site directed antithrombin agents. Implication in drug development.
    Callas D; Fareed J
    Thromb Haemost; 1995 Jul; 74(1):473-81. PubMed ID: 8578509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the dosage of recombinant hirudin to inhibit arterial thrombosis in baboons.
    Kotzé HF; Lamprecht S; Van Wyk V; Roodt JP; Badenhorst PN
    J Pharm Sci; 2000 May; 89(5):579-85. PubMed ID: 10756323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serious bleeding in a haemodialysis patient treated with recombinant hirudin.
    Müller A; Huhle G; Nowack R; Birck R; Heene DL; van der Woude FJ
    Nephrol Dial Transplant; 1999 Oct; 14(10):2482-3. PubMed ID: 10528679
    [No Abstract]   [Full Text] [Related]  

  • 9. [The medicinal leech Hirudo medicinalis: clinical use of the animal and therapeutic prospects of hirudin].
    Henriot JM; Chaillot B; Rochette L; Labrude P
    J Pharm Belg; 1990; 45(3):207-18. PubMed ID: 2205717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological relevance of anti-recombinant hirudin antibodies--results from in vitro and in vivo studies.
    Liebe V; Brückmann M; Fischer KG; Haase KK; Borggrefe M; Huhle G
    Semin Thromb Hemost; 2002 Oct; 28(5):483-90. PubMed ID: 12420244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual compatibility of bivalirudin with selected drugs.
    Hartman CA; Faria CE; Mago K
    Am J Health Syst Pharm; 2004 Sep; 61(17):1774, 1776. PubMed ID: 15462247
    [No Abstract]   [Full Text] [Related]  

  • 13. [From fibrinogen and hirudin to synthetic anticoagulants. Rational design of thrombin inhibitors].
    Steinmetzer T; Stürzebecher J
    Pharm Unserer Zeit; 2004; 33(3):196-205. PubMed ID: 15208908
    [No Abstract]   [Full Text] [Related]  

  • 14. Hirudin treatment in a breastfeeding woman.
    Lindhoff-Last E; Willeke A; Thalhammer C; Nowak G; Bauersachs R
    Lancet; 2000 Feb; 355(9202):467-8. PubMed ID: 10841132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-r-hirudin antibodies reveal clinical relevance through direct functional inactivation of r-hirudin or prolongation of r-hirudin's plasma halflife.
    Huhle G; Liebe V; Hudek R; Heene DL
    Thromb Haemost; 2001 May; 85(5):936-8. PubMed ID: 11372692
    [No Abstract]   [Full Text] [Related]  

  • 16. [Anticoagulant peptides and proteins from leeches].
    Zhou Y; Zhu S
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):497-8. PubMed ID: 11189490
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiovascular drug highlight: hirudin.
    Cheng-Lai A
    Heart Dis; 1999; 1(1):41-9. PubMed ID: 11720603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacology of recombinant hirudin.
    Nowak G
    Semin Thromb Hemost; 2002 Oct; 28(5):415-24. PubMed ID: 12420236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trials of recombinant hirudin in acute coronary syndromes.
    Challapalli R; Lefkovits J; Topol EJ
    Coron Artery Dis; 1996 Jun; 7(6):429-37. PubMed ID: 8889358
    [No Abstract]   [Full Text] [Related]  

  • 20. Hirudins--new antithrombotic agent.
    Katira R; Puri VK
    J Assoc Physicians India; 1994 Mar; 42(3):240-1. PubMed ID: 7860517
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.